Positive Outlook for Carl Zeiss Meditec>
Positive Outlook for Carl Zeiss Meditec
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ JENA/Germany - 17 July 2009.Carl Zeiss Meditec AG, listed in the TecDAX at the German StockExchange, is to continue the path of focus and growth initiated ayear ago with Dr. Michael Kaschke (52) as President and CEO. Dr.Kaschke has resigned his suspended membership of the SupervisoryBoard."The entire Supervisory Board is impressed by the results achieved.With a targeted strategic direction, it has proved possible under Dr.Kaschke's leadership to keep the company on a path of success andgrowth even in these difficult economic times. For that reason, wewill continue to put our trust in continuity," explained Dr. MarkusGuthoff, Chairman of the Supervisory Board of Carl Zeiss Meditec AG."With a targeted focus on innovation, customer orientation and growthmarkets, we are posting pleasing results even in the context of thecurrent economic situation. We will continue to invest infuture-oriented topics. We can confirm our statement that Carl ZeissMeditec will continue to grow while keeping the profitability stableand increasing it in the medium term. Compared to last year, weanticipate revenue growth of at least 5 percent in this currentadverse year," concluded Dr. Michael Kaschke, President and CEO ofCarl Zeiss Meditec AG.Press contacts:Eva SesselmannDirector Corporate CommunicationsCarl Zeiss Meditec AGGöschwitzer Straÿe 51-5207745 JenaPhone: +49 3641 220-331Fax: +49 3641 220-112E-mail: press(at)meditec.zeiss.comPatrick KoflerDirector Investor RelationsCarl Zeiss Meditec AGGöschwitzer Straÿe 51-5207745 JenaPhone: +49 3641 220-106Fax: +49 3641 220-117E-mail: investors(at)meditec.zeiss.comBrief profileCarl Zeiss Meditec AG (ISIN: DE 0005313704) is listed in the Tec-DAXof the Deutsche Börse and is one of the world's leading medicaltechnology suppliers.The company supplies innovative technologies and application-orientedsolutions designed to help doctors improve the quality of life oftheir patients. It provides complete packages of solutions for thediagnosis and treatment of eye diseases - including implants andconsumable materials. The company creates innovative visualisationsolutions in the field of microsurgery. Carl Zeiss Meditec's medicaltechnology portfolio is rounded off by promising future technologiessuch as intraoperative radiation therapy.In the 2007/2008 (30 September) financial year the 2,100 employeesgenerated revenue of approximately 600 EUR million. The head officeof Carl Zeiss Meditec is in Jena, Germany. The company hassubsidiaries in Germany and abroad; more than 50 percent of itsemployees are based in the USA, Japan, Spain and France.35 percent of Carl Zeiss Meditec shares are in free float. Theremaining 65 percent are held by Carl Zeiss AG, one of the world'sleading groups engaged in the optical and opto-electronics industry.The five independently managed business units of Carl Zeiss AGoperate in the future-oriented markets of "Medical and ResearchSolutions", "Industrial Solutions" and "Lifestyle Products". The headoffice of Carl Zeiss AG is in Oberkochen, Germany. In the 2007/08financial year (balance sheet date 30 September) the group postedsales of ? 2.7 billion. Carl Zeiss has a total workforce of about13,000 in over 30 countries, over 8,000 of them in Germany.Further information: http://www.meditec.zeiss.com --- End of Message ---Carl Zeiss Meditec AGGoeschwitzer Strasse 51-52 Jena GermanyWKN: 531370; ISIN: DE0005313704; Index: Prime All Share, TECH All Share, TecDAX;Listed: Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Prime Standard in Frankfurter Wertpapierbörse, Regulierter Markt in Frankfurter Wertpapierbörse;
" alt="IT market continues to be weak, Tieto's profitability improves
slightly from the first quarter>">
" alt="ELISA'S INTERIM REPORT JANUARY-JUNE 2009>">
Datum: 17.07.2009 - 07:22 Uhr
Sprache: Deutsch
News-ID 3674
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 288 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Positive Outlook for Carl Zeiss Meditec>"
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
